EQS: latest releases

• Burcon is a global technology leader in the development of plant-based proteins.
• In 2019, Merit Functional Foods Corporation was established in a joint venture by Burcon and three veteran food industry executives.
• Forward-looking statements or forward-looking information involve risks, uncertainties and other factors that could cause actual results, performances, prospects and opportunities to differ materially from those expressed or implied by such forward-looking statements.
• Although Burcon believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance, and accordingly, investors should not rely on such statements.

• (b)Owner or controller of interests and short positions disclosed, if different from 1(a):
  The naming of nominee or vehicle companies is insufficient.
• For a trust, the trustee(s), settlor and beneficiaries must be named.
• (c)Name of offeror/offeree in relation to whose relevant securities this form relates:
  (d)If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
  For an opening position disclosure, state the latest practicable date prior to the disclosure
  (f)In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
• If it is a cash offer or possible cash offer, state "N/A"
  If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

• Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR), transmitted by EQS Group.
• The issuer is solely responsible for the content of this announcement.
• This announcement contains price sensitive information.
• As at the close of business on 31 August 2020, the unaudited cum and ex-dividend net asset value of the Company's Ordinary Shares (1) was 102.9p (31 July 2020: ex-dividend 102.74p).

• The agreement represents a step change in sales as total revenues for H120 were 2.4m, of which IHT was only 0.3m.
• About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac.
• The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise.At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders.
• Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Chelverton UK Dividend Trust plc: Net Asset Value(s)
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
The Net Asset Value (NAV) at 17/09/2020 was:
Number of shares in issue:

Rights and Issues Investment Trust PLC: Net Asset Value(s)
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

• Advanced Blockchain AG (ISIN DE000A0M93V6) is pleased to report the latest positive developments with regards to its token investments.
• As detailed in our news release from 27.05.2020, Advanced Blockchain AG's token investments, in particular the Polkadot project ( www.polkadot.network ) and Energy Web Token (EWT; www.energyweb.org ) have positively developed.
• Overall, our token investments - in addition to Polkadot and EWT, also COTI ( www.coti.io ) - achieved a largely unrealized seven-figure profit.
• The portfolio of investments will continue to be managed and maintained by Advanced Blockchain AG.

• The Nordex Group has received a 312 MW order in the USA.
• For a wind farm in Texas, the manufacturer will supply 65 N149/4.0-4.5 turbines in the 4.8 MW operating mode.
• These turbines exceed the average nominal capacity of last year's installed onshore turbines by more than 2 MW in the USA," says Patxi Landa, CSO of the Nordex Group.
• Also in the first half 2020 the vast majority of turbines installed are rated between 2 MW to less than 3 MW.

• The EFOY fuel cell will supply the ePropulsion Spirit 1.0 PLUS outboard electric motor for even more range and autonomy.
• In its print edition 19/2020, Europe's largest sailing magazine " Yacht " selected the ePropulsion Spirit 1.0 PLUS as the winner of an electric outboard motor comparative test.
• All sailors and boaters who want to increase the engine's running time can now do it easily and comfortably with the EFOY direct methanol fuel cell.
• With more than 45,000 fuel cells sold worldwide, SFC Energy is a sustainably profitable fuel cell producer.

• Reference building for the new product focus on urban districts, pipeline filled with numerous projects
  City of Nuremberg to rent approx.
• CORESTATE Capital Group S.A. (Corestate), a leading independent real estate investment manager in Europe, has acquired the main part of the Trophy city quarter development "The Q" in Nuremberg for an institutional investment mandate from Bayerische Versorgungskammer (BVK).
• The property will be developed into one of the most modern urban districts in Germany by the Dsseldorf-based seller, Gerchgroup.
• Corestate is consistently expanding its new product focus on city quarters and intensifying its investment activities in the "core" segment.

• A tenancy agreement for this property with a long-term tenant for a term of 10 years from completion was already agreed before construction work began.
• "The Interpark location near Ingolstadt is proving to be a very stable basis for our portfolio, as is the businessPark in Regensburg.
• This has already been demonstrated by the early extensions to the rental agreements with one of our top 10 tenants in Interpark," commented Martin Pfandzelter, VIB Vermgen AG's CEO.
• "The fact that we are once again constructing a property with a long-term rental agreement confirms the quality of the location," he adds.

• MOR210/TJ210 is thought to block the interaction between C5a and C5aR1 by binding to C5aR1 and retard the migration of suppressor cells.
• "The FDA clearance of the IND application to initiate a Phase 1 clinical trial of MOR210/TJ210 is an important step forward in developing a new treatment for patients with advanced cancer", said Dr Malte Peters, Chief Research & Development Officer of MorphoSys.
• MorphoSys and I-Mab entered into an exclusive strategic collaboration and licensing agreement to develop and commercialize MOR210/TJ210 in November 2018.
• Headquartered near Munich, Germany, the MorphoSys group, including the fully owned U.S. subsidiary MorphoSys US Inc., has ~500 employees.